Business Context and Reporting Period
This Form 8-K Current Report from AngioDynamics, Inc. covers events occurring on October 18, 2010, specifically the company's 2010 Annual Meeting of Shareholders. The filing details corporate governance actions, including the election of directors, the ratification of auditors, and amendments to employee compensation plans.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Corporate Actions
- Employee Stock Purchase Plan Amendment: Shareholders approved an amendment to increase the total number of shares available under the plan from 400,000 to 700,000 shares.
- Board of Directors Election: Three Class I directors were elected to serve until the 2013 Annual Meeting: Jeffrey G. Gold, Kevin J. Gould, and Dennis S. Meteny.
- Auditor Ratification: Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2011.
Voting Results and Management Commentary
The filing provides specific vote tallies for the three proposals submitted at the Annual Meeting:
| Proposal | Votes For | Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|---|
| Election of Directors (Jeffrey G. Gold) | 20,174,236 | 915,395 | N/A | 2,223,986 |
| Election of Directors (Kevin J. Gould) | 20,489,355 | 600,276 | N/A | 2,223,986 |
| Election of Directors (Dennis S. Meteny) | 20,533,076 | 556,555 | N/A | 2,223,986 |
| Ratification of PricewaterhouseCoopers LLP | 23,256,357 | 55,558 | 1,702 | 0 |
| Amendment to Employee Stock Purchase Plan | 20,047,794 | 386,820 | 655,017 | 2,223,986 |
Management commentary, forward-looking guidance, risk factors, and contingencies are not included in this specific filing.
Key Facts for Investor Verification
- Verify the dilution impact of the increased share authorization (from 400,000 to 700,000 shares) under the Employee Stock Purchase Plan.
- Confirm the tenure of the newly elected Class I directors, who serve until the 2013 Annual Meeting.
- Note that the filing references the definitive Proxy Statement (Schedule 14A) for detailed descriptions of the plan features and director biographies.